Systematic (IUPAC) name | |
---|---|
5-(1,4-diazepane-1-sulfonyl)isoquinoline | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Pregnancy cat. | ? |
Legal status | ? |
Pharmacokinetic data | |
Bioavailability | well absorbed |
Metabolism | metabolized quickly to hydroxyfasudil |
Half-life | 0.76 hours. Active metabolite (hydroxyfasudil) 4.66 hours. |
Identifiers | |
CAS number | 103745-39-7 |
ATC code | C04AX32 |
PubChem | CID 3547 |
UNII | Q0CH43PGXS |
KEGG | D07941 |
ChEMBL | CHEMBL38380 |
Chemical data | |
Formula | C14H17N3O2S |
Mol. mass | 291.36 g/mol |
SMILES | eMolecules & PubChem |
(verify) |
(what is this?)
Fasudil Hydrochloride (INN) is a potent Rho-kinase inhibitor and vasodilator.[1] Since it was discovered, it has been used for the treatment of cerebral vasospasm, which is often due to subarachnoid hemorrhage,[2] as well as to improve the cognitive decline seen in stroke victims. It has been found to be effective for the treatment of pulmonary hypertension.[3] It was demonstrated in February 2009 that Fasudil could also be used to enhance memory and improve the prognosis of Alzheimers patients.[4]
|